Data / Form D filings / CannaVerde Pharma Inc
CannaVerde Pharma Inc: Form D filing
CannaVerde Pharma Inc, a company in Vancouver, British Columbia, Canada, filed a Form D with the SEC in 2019. The latest, on February 14, 2019, reports $11,195 sold of a $11,195 offering to 1 investor.
Find out what CannaVerde Pharma Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1240 - 1140 WEST PENDER STREET, Vancouver, British Columbia, Canada, V6E 4
- Phone
- (778) 227-0071
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Year incorporated
- 2017
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1764268
The full lists. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 14, 2019 | New notice | $11,195 | $11,195 | $0 | 1 | Dec 17, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sebastian De Kloet | Director | |
| Michael Nistorescu | Executive Officer, Director | |
| Paul Robertson | Executive Officer, Director |
Every Form D from the week of Feb 11, 2019 · All recent Other filings
Read from SEC EDGAR. Amount sold is what CannaVerde Pharma Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.